WANY
TNDM icon

Wealthspire Advisors (New York)’s Tandem Diabetes Care TNDM Stock Holding History

Wealthspire Advisors (New York)’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-330
Closed -$4.01K – 2733
2025
Q3 		$4.01K Buy
+330
New +$4.47K ﹤0.01% 2408

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wealthspire Advisors (New York)'s TNDM Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Tandem Diabetes Care (TNDM) in Q4 2025, closing a stake of 330 shares — an estimated $4.01K sold.

Wealthspire Advisors (New York) first reported a position in TNDM in Q3 2025 and held it in 1 quarter. The position peaked at $4.01K in Q3 2025. 269 funds tracked by Wall St. Rank hold TNDM as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Tandem Diabetes Care position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 330 Tandem Diabetes Care shares in Q4 2025, an estimated $4.01K.
  • Wealthspire Advisors (New York) first reported a position in Tandem Diabetes Care in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Tandem Diabetes Care position peaked at $4.01K in Q3 2025.
  • 269 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.